LAUREN BAUMA: Open Payments
NPI 1245932003 · TRENTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$416 in 26 payments from 10 companies in 2025. Trend: 2023 $233 · 2024 $338 · 2025 $416
Food & beverage: $413Education: $3
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $151 |
| Merck Sharp & Dohme LLC | 4 | $71 |
| Amgen Inc. | 3 | $52 |
| BridgeBio Pharma, Inc. | 2 | $31 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $30 |
| MEDICOMP INC | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Ionis Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: VYNDAQEL, VERQUVO, Repatha, ELIQUIS, Attruby, JARDIANCE, TELEPATCH CARDIAC MONITOR, LEQVIO.
Industry payments across NJ — which companies pay providers there.
